Last quarter (Q4 2022), EKF Diagnostics Holdings's total revenue was £―, a decrease of ― from the same quarter last year. In Q4, EKF Diagnostics Holdings's net income was £―. See EKF Diagnostics Holdings’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 22	Dec 21	Dec 20	Dec 19	Dec 18
Total Revenue	-	£ 67.55M	£ 81.84M	£ 65.26M	£ 44.92M	£ 42.54M
Cost of Revenue	-	£ 42.60M	£ 42.47M	£ 27.84M	£ 21.19M	£ 19.85M
Gross Profit	-	£ 24.96M	£ 39.37M	£ 37.42M	£ 23.73M	£ 22.70M
Operating Expense	-	£ 23.18M	£ 17.62M	£ 20.52M	£ 17.94M	£ 10.50M
Operating Income	-	£ 1.78M	£ 21.75M	£ 16.89M	£ 5.78M	£ 12.20M
Net Non Operating Interest Income Expense	-	£ 29.00K	£ 23.00K	£ -23.00K	£ -266.00K	£ 8.00K
Other Income Expense	-	-	-	-	-	-
Pretax Income	-	£ -8.94M	£ 21.43M	£ 15.36M	£ 5.52M	£ 12.16M
Tax Provision	-	£ 634.00K	£ 5.28M	£ 3.97M	£ 1.59M	£ 1.87M
Earnings From Equity Interest Net Of Tax	-	-	-	-	-	-
Net Income Common Stockholders	-	£ -10.10M	£ 15.85M	£ 11.11M	£ 3.68M	£ 10.11M
Basic EPS	-	£ -0.02	£ 0.03	£ 0.02	£ <0.01	£ 0.02
Diluted EPS	-	£ -0.02	£ 0.03	£ 0.02	£ <0.01	£ 0.02
Basic Average Shares	-	£ 457.18M	£ 457.00M	£ 454.52M	£ 454.09M	£ 457.21M
Diluted Average Shares	-	£ 457.18M	£ 460.96M	£ 458.80M	£ 458.41M	£ 461.49M
Dividend Per Share	-	£ 0.01	£ 0.01	£ 0.01	-	-
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	£ 0.01	£ 0.01
Reported Normalized Diluted E P S	-	-	-	-	-	-
Rent Expense Supplemental	-	-	-	-	£ 0.00	£ 487.00K
Total Expenses	-	£ 65.77M	£ -60.09M	£ 48.37M	£ 39.13M	£ 30.34M
Net Income From Continuing And Discontinued Operation	-	£ -10.10M	£ 15.85M	£ 11.11M	£ 3.68M	£ 10.11M
Normalized Income	-	£ 3.51M	£ 17.36M	£ 12.24M	£ 3.68M	£ 10.15M
Interest Expense	-	-	-	£ 76.00K	£ 58.00K	£ 35.00K
EBIT	-	£ -8.89M	£ 21.50M	£ 15.43M	£ 5.58M	£ 12.20M
EBITDA	-	£ -2.23M	£ 21.50M	£ 20.04M	£ 10.02M	£ 16.19M

Currency in GBP

EKF Diagnostics Holdings Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing